Li, Jingao
Jiangxi Provincial Cancer Hospital
2 papers on CoChatORCID 0000-0002-0389-7576
Most cited papers
- Verified
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
Yang, Y., Qu, S., Li, J., Hu, C., Xu, M., Li, W., Zhou, T., Shen, L., Wu, H., Lang, J., et al. (2021) · The Lancet Oncology
Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers
Cited by 462
- Verified
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial
Ma, Y., Yang, Y., Huang, Y., Fang, W., Xue, J., Meng, X., Fan, Y., Fu, S., Wu, L., Zheng, Y., et al. (2025) · Nature Medicine
Monoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers
Cited by 122
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free